Edgestream Partners, L.P.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1535061
Princeton, NJ
Position in SUPN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,096,310
-$1,874,584 QoQ
Shares Held
66,573
-33.4% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#85
of 333 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Edgestream Partners, L.P. holds $13,084,437 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (23.7% of the industry book) .
All Filings in SUPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,096,310 | 66,573 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $4,970,894 | 100,018 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | $2,028,800 | 75,843 | Shares | Sole | 2024-08-09 | |
| 2023-09-30 | $249,811 | 9,061 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $219,017 | 7,286 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||